Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 29 Aug 2022  |  Global  |  Technology Research

    Advancements in miRNA: Technology Assessment

    Developments in miRNA sequencing and analysis are driving future growth potential in therapeutics and diagnostics

    Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical validation of miRNA diagnostic tests has ...

    $4,950.00
  2. 26 Aug 2022  |  Global  |  Market Research

    Global Hospital Operational Efficiency Solutions

    Visionary Perspectives for Medtech to Help Health Systems Improve Operational Efficiencies and Achieve Transformational Growth

    Hospitals are complex to manage and historically have faced various inefficiencies. After the COIVD-19 pandemic took a toll on hospitals’ financial resources and human capital, efficiency has become a major focus. Automated solutions are key to supporting already strained staff (reeling under shortages and burnout) and enhancing processes, which ...

    $2,450.00
  3. 23 Aug 2022  |  North America  |  Market Research

    Global Bioanalytical Testing Services, 2021–2027

    Acquisition of Disruptive Technologies will be the Key to Driving Growth

    As the pharma market recovers from the debilitating impact of COVID-19 on the drug discovery and development pipelines, there is an increasing requirement for outsourcing services in the form of contract research organizations (CROs) and contract development & manufacturing organizations (CDMOs), which is likely to drive the already strong drug dev...

    $4,950.00
  4. 23 Aug 2022  |  North America  |  Frost Radar

    Frost Radar™: US Liquid Biopsy, 2022

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...

    $4,950.00
  5. 19 Aug 2022  |  North America  |  Market Research

    Global Antibody Therapeutics Growth Opportunities

    The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth

    Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...

    $2,450.00
  6. 19 Aug 2022  |  Global  |  Market Research

    Digital Front Door and Patient Experience Solutions

    Healthcare is Being Propelled into a Consumer-centric Marketplace

    Frost & Sullivan has identified that the healthcare industry is witnessing massive disruption because of the digital revolution and competitive threats from new market entrants. COVID-19 exposed the strengths and weaknesses of healthcare organizations already striving to digitally transform their operations and create retail-like patient experi...

    $2,450.00
  7. 19 Aug 2022  |  North America  |  Frost Radar

    Frost Radar™: Healthcare Data Analytics, 2022

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    Healthcare organizations must be able to manage, analyze, and interpret data in order to identify strategic, tactical, and operational insights for decision making. This allows providers and payers to provide the best ways of delivering high-quality care. There has been a slow but steady change in the healthcare industry at the very core of its bus...

    $4,950.00
  8. 17 Aug 2022  |  Global  |  Technology Research

    Therapeutic Advances in Amyloidosis

    Research Efforts and Technology Developments through Partnerships and Collaborations will Push New Therapeutic Modalities into Treatment Regimens.

    Amyloidosis is a rare disease caused by the accumulation and the deposition of proteins such as immunoglobulin light-chain protein in AL amyloidosis and misfolded transthyretin (TTR) protein in ATTR amyloidosis. There are a few other types of amyloidosis as well, which are either a result of a preexisting condition or are not highly prevalent. Vari...

    $4,950.00
  9. 17 Aug 2022  |  North America  |  Frost Radar

    Frost Radar™: Global Clinical Trial IT Solutions Market, 2022

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    COVID-19 has accelerated the need for a faster, more accessible clinical trial process. During the height of the pandemic, in-person follow-ups for ongoing trials were replaced with hand-held devices that essentially built an ecosystem for home health care support services that can be easily leveraged to avoid or reduce participant dropout rates. ...

    $4,950.00
  10. 16 Aug 2022  |  North America  |  Market Research

    Global Cell and Gene Therapy (CGT) Growth Opportunities

    The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain

    This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...

    $4,950.00